The global antibiotics market is poised for steady growth, driven by the rising prevalence of bacterial infections and increasing demand for effective treatments. This article provides an in-depth analysis of the current market landscape, key players, recent developments, and future prospects.
In its latest study, Fortune Business Insights, the global antibiotics market was valued at USD 39.73 billion in 2023 and is projected to increase from USD 40.66 billion in 2024 to USD 51.88 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period (2024-2032).
Request a Free Sample PDF Brochure of Antibiotics Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/antibiotics-market-104583
In March 2024, Wockhardt announced that its investigational antibiotic under-trial drug, Zidebactam/Cefepime, depicted successful results in treating a highly drug-resistant skull bone infection and pneumonia in a renal transplant patient.